2025-04-04 19:35:41
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Astec LifeSciences' consolidated PAT surges in Q3FY22 to Rs. 24.74 crore
Posted On : 2022-01-26 00:00:28( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 175.3130 crores during the period ended December 31, 2021 as compared to Rs. 103.4737 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 24.7468 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 9.0724 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 12.62 for the period ended December 31, 2021 as compared to Rs. 4.63 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 175.3130 crs | ₹103.4737 crs |  69.43% |
| Net Profit | ₹24.7468 crs | ₹9.0724 crs | 172.77% |
| EPS | ₹12.62 | ₹4.63 | 172.57% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 175.3130 crores during the period ended December 31, 2021 as compared to Rs.119.2803 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.24.7468 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.7.0579 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.12.62 for the period ended December 31, 2021 as compared to Rs.3.60 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 175.3130 crs | ₹119.2803 crs | 46.98% |
| Net Profit | ₹24.7468 crs | ₹7.0579 crs | 250.63% |
| EPS | ₹12.62 | ₹3.60 | 250.56% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.408.2471 crores during the 9 Months period ended December 31, 2021 as compared to Rs.389.3236 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.46.8040 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.41.0893 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.23.88 for the 9 Months period ended December 31, 2021 as compared to Rs.20.97 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹408.2471 crs | ₹389.3236 crs | 4.86% |
| Net Profit | ₹46.8040 crs | ₹41.0893 crs | 13.91% |
| EPS | ₹23.88 | ₹20.97 | 13.88% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1732.25 as compared to the previous close of Rs. 1690.50. The total number of shares traded during the day was 9436 in over 1915 trades.
The stock hit an intraday high of Rs. 1820.20 and intraday low of 1667.10. The net turnover during the day was Rs. 16552786.00.
